ACLARIS THERAPEUTICS INC's ticker is ACRS and the CUSIP is 00461U105. A total of 127 filers reported holding ACLARIS THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.21 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $177,415 | -74.0% | 25,900 | -69.3% | 0.00% | -100.0% |
| Q1 2023 | $683,136 | +305.4% | 84,442 | +689.2% | 0.00% | +100.0% |
| Q4 2022 | $168,525 | -11.3% | 10,700 | -18.0% | 0.00% | – |
| Q4 2021 | $190,000 | -90.4% | 13,044 | -88.1% | 0.00% | -100.0% |
| Q3 2021 | $1,977,000 | -70.0% | 109,828 | -70.7% | 0.00% | -73.3% |
| Q2 2021 | $6,590,000 | +50.2% | 375,302 | +115.6% | 0.02% | +36.4% |
| Q1 2021 | $4,387,000 | +687.6% | 174,076 | +102.2% | 0.01% | +450.0% |
| Q4 2020 | $557,000 | +254.8% | 86,092 | +20.3% | 0.00% | +100.0% |
| Q2 2019 | $157,000 | -84.0% | 71,581 | -56.3% | 0.00% | -66.7% |
| Q1 2019 | $981,000 | +26.1% | 163,697 | +55.4% | 0.00% | 0.0% |
| Q4 2018 | $778,000 | – | 105,329 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management V, LLC | 1,258,243 | $8,618,965 | 13.75% |
| Foresite Capital Management IV, LLC | 2,808,034 | $19,235,033 | 10.68% |
| Bain Capital Life Sciences Investors, LLC | 3,400,000 | $23,290,000 | 2.60% |
| GREAT POINT PARTNERS LLC | 1,691,768 | $11,588,611 | 2.11% |
| Samsara BioCapital, LLC | 696,171 | $4,768,771 | 1.46% |
| Altium Capital Management LP | 403,000 | $2,760,550 | 1.44% |
| BVF INC/IL | 7,064,736 | $48,393,442 | 1.30% |
| Aisling Capital Management LP | 434,455 | $2,976,017 | 1.23% |
| GREAT POINT PARTNERS LLC | 700,000 | $4,795,000 | 0.87% |
| VR Adviser, LLC | 1,040,754 | $7,129,165 | 0.75% |